A Study of Baricitinib (LY3009104) in Children With COVID-19

Clinical trial NCT05074420 · TERMINATED

Trial details

NCT number: NCT05074420
Sponsor: Eli Lilly and Company
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Covid19 Corona Virus Infection

Start date: 2021-12-21
Primary completion: 2024-09-05
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.